MR-based Hypofractionated Adaptive IGRT of Prostate Cancer (M-base HyPro 2.0)

NCT03880851 · clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
78
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University Hospital Tuebingen